Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer
2012 · British Journal of Cancer · 47 citations
https://doi.org/10.1038/bjc.2012.434
D
Deniz Gencer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
970
Citations
12
h-index
14
i10-index
Deniz Gencer is an academic researcher from Istanbul Medipol University. The author has contributed to research in topics: Palliative Care and End-of-Life Issues & Cancer survivorship and care & Diverse Scientific and Economic Studies. The author has an h-index of 12, co-authored 60 publications.
ORCID: 0000-0003-3004-8155Papers by this author
worksExpression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
2011 · BMC Cancer · 43 citations
https://doi.org/10.1186/1471-2407-11-363
Feasibility, use and benefits of patient-reported outcome measures in palliative care units: a multicentre observational study
2023 · BMC Palliative Care · 34 citations
https://doi.org/10.1186/s12904-022-01123-y
The views of physicians and nurses on the potentials of an electronic assessment system for recognizing the needs of patients in palliative care
2020 · BMC Palliative Care · 27 citations
https://doi.org/10.1186/s12904-020-00554-9
Burnout among German oncologists: a cross-sectional study in cooperation with the Arbeitsgemeinschaft Internistische Onkologie Quality of Life Working Group
2022 · Journal of Cancer Research and Clinical Oncology · 6 citations
https://doi.org/10.1007/s00432-022-03937-y
Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany
2021 · Journal of Cancer Research and Clinical Oncology · 2 citations
https://doi.org/10.1007/s00432-021-03652-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat